4.8 Article

Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci

Journal

NATURE GENETICS
Volume 48, Issue 5, Pages 510-+

Publisher

NATURE PORTFOLIO
DOI: 10.1038/ng.3528

Keywords

-

Funding

  1. German Federal Ministry of Education and Research (BMBF) [01ZX1306A]
  2. Estonian Research Council [IUT20-60]
  3. Center of Excellence in Genomics (EXCEGEN)
  4. University of Tartu (SP1GVARENG)
  5. UK Department of Health via National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St Thomas' National Health Service (NHS) Foundation Trust
  6. King's College London
  7. University of Cambridge
  8. German Federal Ministry of Education and Research (BMBF), within the context of National Genome Research Network [2 (NGFN-2)]
  9. National Genome Research Network plus (NGFNplus)
  10. Integrated Genome Research Network (IG) MooDS [01GS08144, 01GS08147]
  11. Netherlands Organization for Scientific Research (NWO) [016.136.308]
  12. Swedish Research Council [521-2011-2764]
  13. US NIH [1R01AR063759, 5U01GM092691-05, 1UH2AR067677-01, U19AI111224-01, 1R01DK084960-05]
  14. Doris Duke Charitable Foundation [2013097]
  15. Novo Nordisk Foundation [NNF14CC0001]
  16. H2020 project MedBioinformatics [634143]
  17. Norwegian PSC Research Center
  18. German Federal Ministry of Education and Research (BMBF) [01ZX1306A]
  19. Estonian Research Council [IUT20-60]
  20. Center of Excellence in Genomics (EXCEGEN)
  21. University of Tartu (SP1GVARENG)
  22. UK Department of Health via National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St Thomas' National Health Service (NHS) Foundation Trust
  23. King's College London
  24. University of Cambridge
  25. German Federal Ministry of Education and Research (BMBF), within the context of National Genome Research Network [2 (NGFN-2)]
  26. National Genome Research Network plus (NGFNplus)
  27. Integrated Genome Research Network (IG) MooDS [01GS08144, 01GS08147]
  28. Netherlands Organization for Scientific Research (NWO) [016.136.308]
  29. Swedish Research Council [521-2011-2764]
  30. US NIH [1R01AR063759, 5U01GM092691-05, 1UH2AR067677-01, U19AI111224-01, 1R01DK084960-05]
  31. Doris Duke Charitable Foundation [2013097]
  32. Novo Nordisk Foundation [NNF14CC0001]
  33. H2020 project MedBioinformatics [634143]
  34. Norwegian PSC Research Center
  35. MRC [G0800675] Funding Source: UKRI
  36. Crohn's and Colitis UK [M11-1] Funding Source: researchfish
  37. Lundbeck Foundation [R190-2014-3904] Funding Source: researchfish
  38. Medical Research Council [G0800675] Funding Source: researchfish
  39. Medical Research Foundation [C0482] Funding Source: researchfish
  40. NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish
  41. Novo Nordisk Foundation Center for Protein Research [PI Søren Brunak] Funding Source: researchfish

Ask authors/readers for more resources

We simultaneously investigated the genetic landscape of ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis and ulcerative colitis to investigate pleiotropy and the relationship between these clinically related diseases. Using high-density genotype data from more than 86,000 individuals of European ancestry, we identified 244 independent multidisease signals, including 27 new genome-wide significant susceptibility loci and 3 unreported shared risk loci. Complex pleiotropy was supported when contrasting multidisease signals with expression data sets from human, rat and mouse together with epigenetic and expressed enhancer profiles. The comorbidities among the five immune diseases were best explained by biological pleiotropy rather than heterogeneity (a subgroup of cases genetically identical to those with another disease, possibly owing to diagnostic misclassification, molecular subtypes or excessive comorbidity). In particular, the strong comorbidity between primary sclerosing cholangitis and inflammatory bowel disease is likely the result of a unique disease, which is genetically distinct from classical inflammatory bowel disease phenotypes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available